|
English
|
正體中文
|
简体中文
|
2822924
|
|
???header.visitor??? :
30016875
???header.onlineuser??? :
1135
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"dougados m"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 中山醫學大學 |
2020 |
Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)
|
Dougados, M; Wei, JCC; Landewe, R; Sieper, J; Baraliakos, X; Van den Bosch, F; Maksymowych, WP; Ermann, J; Walsh, JA; Tomita, T; Deodhar, A; van der Heijde, D; Li, XQ; Zhao, FY; Bertram, CC; Gallo, G; Carlier, H; Gensler, LS |
| 中山醫學大學 |
2020 |
Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks
|
Marzo-Ortega, H; Mease, PJ; Rahman, P; Navarro-Compan, V; Strand, V; Dougados, M; Combe, B; Wei, JCC; Baraliakos, X; Hunter, T; Sandoval, D; Li, XQ; Zhu, BJ; Bessette, L; Deodhar, A |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
